Skip to main content
OpenTrials
Completed

NCT Number: NCT00000321

Methamphetamine Abuse Treatment in Patients With AIDS - 1

The purpose of this study is to evaluate the efficacy of desipramine, sertraline, and placebo on methamphetamine dependent gay men with AIDS.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Substance-related Disorders Chemically-Induced Disorders Mental Disorders

Sex eligibility

Male

Study type

Interventional

Phase

Phase 4

Primary location

Friends Research Institute

Los Angeles, California, 90025, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Please contact site for information.

Treatment and study plan

Desipramine

Drug

Primary outcomes

  1. Craving

  2. Retention

  3. Depression

  4. Methamphetamine use

  5. Anxiety and Depression

  6. ASI Scales (7)

  7. AIDS medical care engagement

  8. High risk sexual behaviors

  9. Mood indicators

Sponsors and collaborators

Lead sponsor

National Institute on Drug Abuse (NIDA)

Nih

Collaborators

  • Friends Research Institute, Inc.

Registry information

Official study title

Methamphetamine Abuse Pharmacology in Patients With AIDS

Important dates

Study start
1996
Study completion
2001
First posted
Sep 21, 1999
Registry last updated
Jan 12, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.